Mitochondrial abnormalities in Alzheimer's disease

被引:1113
|
作者
Hirai, K
Aliev, G
Nunomura, A
Fujioka, H
Russell, RL
Atwood, CS
Johnson, AB
Kress, Y
Vinters, HV
Tabaton, M
Shimohama, S
Cash, AD
Siedlak, SL
Harris, PLR
Jones, PK
Petersen, RB
Perry, G
Smith, MA
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA
[4] Takeda Chem Ind Ltd, Pharmaceut Res Labs 1, Osaka 5328686, Japan
[5] Takeda Chem Ind Ltd, Div Pharmaceut Res, Osaka 5328686, Japan
[6] Asahikawa Med Coll, Dept Psychiat & Neurol, Asahikawa, Hokkaido 0788510, Japan
[7] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
[8] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA
[9] Univ Genoa, Dept Neurosci, I-16132 Genoa, Italy
[10] Kyoto Univ, Dept Neurol, Kyoto 6068507, Japan
关键词
Alzheimer's disease; free radicals; metabolism; mitochondria; neurodegeneration; oxidative stress;
D O I
10.1523/JNEUROSCI.21-09-03017.2001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The finding that oxidative damage, including that to nucleic acids, in Alzheimer's disease is primarily limited to the cytoplasm of susceptible neuronal populations suggests that mitochondrial abnormalities might be part of the spectrum of chronic oxidative stress of Alzheimer's disease. In this study, we used in situ hybridization to mitochondrial DNA (mtDNA), immunocytochemistry of cytochrome oxidase, and morphometry of electron micrographs of biopsy specimens to determine whether there are mitochondrial abnormalities in Alzheimer's disease and their relationship to oxidative damage marked by 8-hydroxyguanosine and nitrotyrosine. We found that the same neurons showing increased oxidative damage in Alzheimer's disease have a striking and significant increase in mtDNA and cytochrome oxidase. Surprisingly, much of the mtDNA and cytochrome oxidase is found in the neuronal cytoplasm and in the case of mtDNA, the vacuoles associated with lipofuscin. Morphometric analysis showed that mitochondria are significantly reduced in Alzheimer's disease. The relationship shown here between the site and extent of mitochondrial abnormalities and oxidative damage suggests an intimate and early association between these features in Alzheimer's disease.
引用
收藏
页码:3017 / 3023
页数:7
相关论文
共 50 条
  • [41] Mitochondrial function and Alzheimer's disease
    Ojaimi, J
    Byrne, E
    BIOLOGICAL SIGNALS AND RECEPTORS, 2001, 10 (3-4): : 254 - 262
  • [42] Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease
    Terada, Tatsuhiro
    Therriault, Joseph
    Kang, Min Su Peter
    Savard, Melissa
    Pascoal, Tharick Ali
    Lussier, Firoza
    Tissot, Cecile
    Wang, Yi-Ting
    Benedet, Andrea
    Matsudaira, Takashi
    Bunai, Tomoyasu
    Obi, Tomokazu
    Tsukada, Hideo
    Ouchi, Yasuomi
    Rosa-Neto, Pedro
    MOLECULAR NEURODEGENERATION, 2021, 16 (01)
  • [43] Mitochondrial dysfunction and Alzheimer's disease
    Maruszak, Aleksandra
    Zekanowski, Cezary
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02) : 320 - 330
  • [44] Mitochondrial Calcium Signaling as a Therapeutic Target for Alzheimer's Disease
    Wu, Aston J.
    Tong, Benjamin C. -K.
    Huang, Alexis S.
    Li, Min
    Cheung, King-Ho
    CURRENT ALZHEIMER RESEARCH, 2020, 17 (04) : 329 - 343
  • [45] The Alzheimer's Disease Mitochondrial Cascade Hypothesis: A Current Overview
    Swerdlow, Russell H.
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 92 (03) : 751 - 768
  • [46] Current Advances in Mitochondrial Targeted Interventions in Alzheimer's Disease
    Sousa, Tiago
    Moreira, Paula I.
    Cardoso, Susana
    BIOMEDICINES, 2023, 11 (09)
  • [47] Mitochondrial complex I as a therapeutic target for Alzheimer's disease
    Trushina, Eugenia
    Trushin, Sergey
    Hasan, Md Fayad
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (02) : 483 - 495
  • [48] Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease
    Onyango, Isaac G.
    NEURAL REGENERATION RESEARCH, 2018, 13 (01) : 19 - 25
  • [49] VDAC1, mitochondrial dysfunction, and Alzheimer's disease
    Shoshan-Barmatz, Varda
    Nahon-Crystal, Edna
    Shteinfer-Kuzmine, Anna
    Gupta, Rajeev
    PHARMACOLOGICAL RESEARCH, 2018, 131 : 87 - 101
  • [50] Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer's disease
    Yoo, Seung-Min
    Park, Jisu
    Kim, Seo-Hyun
    Jung, Yong-Keun
    BMB REPORTS, 2020, 53 (01) : 35 - 46